A study in human heart tissue from sudden infant death syndrome (SIDS) cases demonstrated that the expression of the mir-133a did not differ significantly between SIDS patients and control cases [Courts et al. DOI:10.1016/j.forsciint.2013.02.032]. A systematic review of human, mouse, rat, and pig tissues indicates that microRNA-133a (miR-133a) demonstrates high stability in myocardium, establishing its potential as a reference control marker for postmortem interval estimation in heart tissue [Cianci et al. DOI:10.3390/ijms25158185].